all AI news
Telix Accelerates AI Development Program Acquiring Dedicaid
AI – AI-TechPark ai-techpark.com
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability with the signing of an agreement to acquire Vienna-based Dedicaid GmbH (Dedicaid), a spin-off of the Medical University Vienna. Dedicaid’s core asset is a clinical decision support software (CDSS) AI platform capable of rapidly...
The post Telix Accelerates AI Development Program Acquiring Dedicaid first appeared on AI-TechPark.
ai ai development ai platform artificial artificial intelligence core decision decision support development expansion intelligence medical pharmaceuticals platform software spin support university